Lim Wee Shiong, Chong Mei Sian, Sahadevan Suresh
Department of Geriatric Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
Clin Med Res. 2007 Mar;5(1):61-70. doi: 10.3121/cmr.2007.693.
Consistent with the worldwide demographic trend of population aging, dementia is expected to become a burgeoning public health problem in Asian populations. Thus, there is a pressing need for reliable and valid methods of dementia diagnosis and staging that are applicable in heterogeneous Asian populations. The Clinical Dementia Rating (CDR) is an informant-based global assessment scale with established reliability and validity that has been widely utilized as a severity-ranking scale in many studies of Asian populations. From a diagnostic standpoint, the CDR is congruent with the Diagnostic and Statistical Manual of Mental Disorders approach of dementia diagnosis. It exhibits excellent discriminatory ability in the very mild stages of dementia, a useful property that is germane to the surging interest in mild cognitive impairment and related concepts. Limitations of the CDR include its length of administration, reliance on clinical judgment and collateral source information, and relative insensitivity as a measure of change in interventional studies. Since the exercise of clinical judgment is inherent in scoring, CDR raters should be mindful of the influence of cultural factors on premorbid lifestyle, informant reliability and performance in certain CDR test items (especially those pertaining to the categories of judgment and problem solving, community, and home and hobbies). Thus, in future studies that involve the nascent use of the CDR in Asian populations, it is recommended that any transcultural adaptation of CDR items be described in detail and appropriate validation studies be carried out before adopting the CDR as a yardstick measure of assessment. The potential of adapted versions of the CDR in chronic care settings and advanced cases should be explored. An integrative approach, combining brief informant interview in conjunction with brief objective cognitive testing, could be a viable strategy for dementia screening in the clinical and research setting that warrants further evaluation in Asian populations.
与全球人口老龄化的人口趋势一致,痴呆症预计将成为亚洲人群中一个迅速发展的公共卫生问题。因此,迫切需要适用于异质亚洲人群的可靠且有效的痴呆症诊断和分期方法。临床痴呆评定量表(CDR)是一种基于知情者的整体评估量表,具有既定的信度和效度,在许多亚洲人群研究中已被广泛用作严重程度分级量表。从诊断角度来看,CDR与《精神疾病诊断与统计手册》中痴呆症诊断方法一致。它在痴呆症极轻微阶段表现出出色的鉴别能力,这一有用特性与对轻度认知障碍及相关概念的兴趣激增密切相关。CDR的局限性包括其施测时间长度、对临床判断和旁证信息的依赖,以及在干预性研究中作为变化衡量指标时相对不敏感。由于评分过程中临床判断是固有的,CDR评分者应注意文化因素对病前生活方式、知情者可靠性以及某些CDR测试项目(特别是与判断和解决问题、社区以及家庭和爱好类别相关的项目)表现的影响。因此,在未来涉及在亚洲人群中初次使用CDR的研究中,建议在将CDR用作评估的标准测量方法之前,详细描述CDR项目的任何跨文化适应性,并进行适当的验证研究。应探索CDR改编版本在长期护理环境和晚期病例中的潜力。将简短的知情者访谈与简短的客观认知测试相结合的综合方法,可能是临床和研究环境中痴呆症筛查的可行策略,值得在亚洲人群中进一步评估。